Literature DB >> 19634592

Statins for secondary cardiovascular disease prevention for older primary care patients.

Richard Niska1, Beth Han.   

Abstract

OBJECTIVES: To examine statin prescribing for secondary cardiovascular disease prevention at primary care visits by older patients in 2005-2006.
DESIGN: The National Ambulatory Medical Care Survey and the National Hospital Ambulatory Medical Care Survey are cross-sectional, using a multistage random sample (112 primary sampling units, physicians and hospitals, patient visits). Characteristics from 4964 primary care visits were abstracted from medical records. Chi2 and logistic regression were performed to investigate associations with statin prescribing.
SETTING: US nonfederal physician offices and hospital outpatient departments. PARTICIPANTS: Visits by patients aged 55 to 80 years with cerebrovascular, ischemic heart or peripheral vascular disease, aortic aneurysm, atherosclerosis, diabetes mellitus, or any 2 risk factors (hyperlipidemia, hypertension, or smoking). MEASUREMENTS: The dependent variable was statin prescribing. Independent variables were age, sex, ethnicity, primary payment source, number of comorbidities, metropolitan statistical area, geographic region, and clinical setting.
RESULTS: Statins were prescribed at 37.7% of visits. Logistic regression negative predictors for statin prescribing included non-Hispanic black ethnicity and Medicaid coverage. Number of comorbidities was a positive predictor.
CONCLUSION: Statins are prescribed at much fewer visits by higher-risk older patients, especially non-Hispanic black patients and Medicaid beneficiaries, than would be expected from their comorbidities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19634592     DOI: 10.1016/s0027-9684(15)30980-9

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  8 in total

Review 1.  Statins in the primary prevention of cardiovascular disease.

Authors:  Željko Reiner
Journal:  Nat Rev Cardiol       Date:  2013-06-04       Impact factor: 32.419

Review 2.  Primary prevention of cardiovascular disease with statins in the elderly.

Authors:  Zeljko Reiner
Journal:  Curr Atheroscler Rep       Date:  2014-07       Impact factor: 5.113

Review 3.  Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly.

Authors:  Sydney B Long; Michael J Blaha; Roger S Blumenthal; Erin D Michos
Journal:  Clin Interv Aging       Date:  2010-12-22       Impact factor: 4.458

4.  The influence of high-dose simvastatin and diltiazem on myocardium in rabbits: a haemodynamic study.

Authors:  Magdalena Jasińska; Jacek Owczarek; Daria Orszulak-Michalak
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

5.  Cardiovascular events and death after myocardial infarction or ischemic stroke in an older Medicare population.

Authors:  Suying Li; Yi Peng; Xinyue Wang; Yi Qian; Pin Xiang; Sally W Wade; Haifeng Guo; J Antonio G Lopez; Charles A Herzog; Yehuda Handelsman
Journal:  Clin Cardiol       Date:  2019-02-25       Impact factor: 2.882

Review 6.  Statins for primary cardiovascular prevention in the elderly.

Authors:  Juan Pedro-Botet; Elisenda Climent; Juan J Chillarón; Rocio Toro; David Benaiges; Juana A Flores-Le Roux
Journal:  J Geriatr Cardiol       Date:  2015-07       Impact factor: 3.327

7.  Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis.

Authors:  Gaetanne K Murphy; Finlay A McAlister; Daniala L Weir; Lisa Tjosvold; Dean T Eurich
Journal:  BMC Public Health       Date:  2014-06-02       Impact factor: 3.295

8.  Effect of Coenzyme Q10 Supplementation in Statin-Treated Obese Rats.

Authors:  Hye-Kyung Choi; Eun-Kyung Won; Se-Young Choung
Journal:  Biomol Ther (Seoul)       Date:  2016-03-01       Impact factor: 4.634

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.